Colicin
Structure of a colicin protein
Colicin is a type of antimicrobial protein produced by certain strains of Escherichia coli bacteria. It is a potent bacteriocin that exhibits a narrow spectrum of activity against closely related bacterial species. Colicins are known for their ability to kill or inhibit the growth of competing bacterial strains, providing a competitive advantage to the producing organism.
Discovery[edit]
Colicins were first discovered in the 1950s by A. J. Clark and Martha K. Geider. They observed that certain strains of E. coli were capable of producing substances that could kill or inhibit the growth of other E. coli strains. These substances were later named colicins.
Structure and Function[edit]
Colicins are large, complex proteins with a variety of structural and functional domains. They are typically composed of three main regions: the N-terminal translocation domain, the central receptor-binding domain, and the C-terminal cytotoxic domain.
The translocation domain allows colicins to cross the outer membrane of target cells and gain access to the periplasmic space. The receptor-binding domain recognizes specific receptors on the surface of target cells, facilitating the binding and subsequent entry of the colicin into the cell. Finally, the cytotoxic domain exerts its antimicrobial activity by disrupting essential cellular processes, such as DNA replication or protein synthesis.
Mechanism of Action[edit]
Colicins employ various mechanisms to kill or inhibit the growth of target bacteria. Some colicins, known as pore-forming colicins, create channels in the cytoplasmic membrane of target cells, leading to the dissipation of the transmembrane potential and cell death. Other colicins, called DNases or RNases, degrade the DNA or RNA of target cells, respectively, disrupting vital cellular processes.
Applications[edit]
Colicins have been extensively studied for their potential applications in various fields. Their antimicrobial properties make them attractive candidates for the development of novel antibiotics. Additionally, colicins have been used as tools in molecular biology research to study bacterial physiology and genetics. They have also been investigated for their potential use in food preservation and as alternatives to traditional chemical preservatives.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian